Recogen 10000IU Injection

About Recogen 10000IU Injection

Recogen 10000IU is an injection of erythropoietin, a hormone-like medicine that signals the bone marrow to make more red blood cells. It is given by a healthcare professional to treat certain types of anemia.

There are 8 brands of Erythropoietin listed in Bangladesh.

What is Recogen 10000IU Injection?

Recogen 10000IU Injection contains erythropoietin, a protein that works like a natural hormone the body makes to stimulate red blood cell production. When the body cannot make enough red blood cells, this medicine encourages the bone marrow to produce more, which can help raise the blood's oxygen-carrying capacity. It is given as an injection by a healthcare professional, usually in a clinic or hospital setting. The doctor decides the dose, the route and how often it is given, and monitors the response with blood tests over time. Recogen 10000IU is supplied by Advanced Chemical Industries PLC in a strength of 10000 IU/ml.

Uses of Recogen 10000IU

Recogen 10000IU is used to treat anemia linked to chronic kidney failure, including in people who are on dialysis and those who are not. It is also used for anemia in some patients with non-myeloid cancers when the anemia is caused by chemotherapy given at the same time. It is not a general energy booster and is only given when a doctor has confirmed the right type of anemia. Ask your doctor whether this treatment is suitable for your condition.

How to use Recogen 10000IU

Recogen 10000IU is given as an injection by a doctor or trained healthcare professional, either into a vein or under the skin. You should not inject it yourself unless your care team has specifically taught you how. The doctor sets the dose and schedule and adjusts them based on blood test results. Keep all appointments for monitoring, and tell your care team about any new symptoms between visits. Store as directed on the pack.

Side effects of Recogen 10000IU

The most common side effect is a rise in blood pressure, which is why blood pressure is checked during treatment. Some people get headache, dizziness, fever, tiredness, joint pain, nausea, vomiting, loss of appetite or diarrhoea. Palpitations and raised potassium levels can occur, and allergic reactions are possible. Tell your doctor promptly about severe headache, swelling, chest symptoms or any reaction after an injection so it can be assessed.

Safety and precautions

Recogen 10000IU is not for people with uncontrolled high blood pressure or a known allergy to erythropoietin or to products made from mammalian cells. Use it with caution if you have controlled high blood pressure, ischaemic vascular disease, a history of seizures or a suspected allergy, and tell your doctor about these. Your iron levels are checked before and during treatment. In pregnancy it is used only when clearly needed; it is not known whether it passes into breast milk, so breastfeeding mothers should ask the doctor first.

Frequently asked questions

What is Recogen 10000IU and what kind of medicine is it?

It is an injection containing erythropoietin, a medicine that stimulates the bone marrow to produce more red blood cells. It belongs to the group of drugs used for certain anemias, including anemia of chronic kidney disease and some chemotherapy-related anemias.

Who should avoid it or ask the doctor first?

People with uncontrolled high blood pressure, or with a known allergy to erythropoietin or to mammalian cell-derived products, should not use it. Ask the doctor first if you have controlled high blood pressure, ischaemic vascular disease, a history of seizures or a suspected allergy.

Is it safe in pregnancy or breastfeeding?

It is used in pregnancy only when clearly needed, because there are no controlled studies in pregnant women. It is not known whether it passes into breast milk, so caution is advised and breastfeeding mothers should speak to their doctor before using it.

How is the injection given and who decides the dose?

It is given by a doctor or trained healthcare professional, either into a vein or under the skin. The doctor decides the dose, the route and how often it is given, and adjusts the plan based on blood test results. Do not inject it yourself unless your care team has taught you.

Indications

Erythropoietin is indicated for the treatment of-
  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • ... Read more
Erythropoietin is indicated for the treatment of-
  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • Anemic patients (hemoglobin >10 to <13 g/dL) are scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions.
  • Anemia related to therapy with zidovudine in HIV-infected patients.

Dosage & Administration

Treatment of anemia in chronic renal failure: Erythropoietin is administered to maintain hemoglobin concentration between 11 to 12 g/dl and hematocrit of 33-36 % in adults.

Starting dose:
  • Adult: Usually 50 to 100 lU/kg three times in a week (TIW) by IV or Subcutaneous route.
  • Pediatric: 50 lU/kg TIW by IV or Subcutaneous route.
Dose adjustment: Dose should be increased if hematocrit doses not increase by 5 to 6 points after 8 weeks therapy, and hematocrit is below suggested target range. Dose should be reduced when hematocrit approaches 36% or hematocrit increases >4 points in any 2-week period.

Maintenance dose: Maintenance dose must be individualized for each patient. In patients undergoing dialysis, the median maintenance dose is 75 lU/kg TIW, with a range from 12.5 to 525 lU/kg TIW as directed by the physician. In CRF patients not on dialysis, maintenance dose is 75 to 150 lU/kg/week.

Treatment of Anemia in Cancer Patients on Chemotherapy:

Starting dose:
  • Adult: 150 lU/kg TIW by Subcutaneous route or 40,000 IU Subcutaneous route weekly.
  • Pediatric: 25 to 300 lU/kg 3 to 7 times per week by Subcutaneous or IV route.
Dose adjustment: If the response is not satisfactory, the dose should be increased to 300 lU/kg TIW. If the hematocrit exceeds 40%, the dose should be withheld until the hematocrit falls to 36%.The dose should be reduced to 25% when treatment is resumed and titrated to maintain the desired hematocrit.

Surgery Patients: The recommended dose is 300 lU/kg/day subcutaneously for 10 days before surgery, on the day of surgery, and for 4 days after surgery. An alternate dose schedule is 600 lU/kg subcutaneously in once weekly dose (21, 14, and 7 days before surgery) plus a fourth dose on the day of surgery.

Zidovudine-treated HIV-infected Patients:
Starting dose
  • Adult: 100 lU/kg as an IV or Subcutaneous injection TIW for 8 weeks.
  • Pediatric: 50 to 400 lU/kg 2 to 3 times per week by Subcutaneous or IV route.
Dose adjustment: If the response is not satisfactory, the dose should be increased by 50-1001U/kg TIW. Response should be evaluated every 4 to 8 weeks thereafter and the dose adjusted accordingly by 50 to 100 lU/kg increments TIW.

Maintenance dose: The dose is titrated to maintain the hematocrit between 33-36%.

Contraindications

Erythropoietin is contraindicated in patients with:
  • Uncontrolled hypertension
  • Known hypersensitivity to mammalian cell-derived products
  • A history of hypersensitivity to Erythropoietin or any component of the preparation.

Side Effects

General: Headache, dizziness, fever, malaise, arthralgia and occasionally hyperkalemia. Cardiovascular: Hypertension is the most common side effect, palpitations. Gastrointestinal: Nausea, vomiting, anorexia and diarrhea may occur occasionally. Allergic reactions.

Pregnancy & Lactation

Pregnancy Category C. Since there are no controlled studies of erythropoietin in pregnant women, and because animal reproduction studies are not always predictive of human responses, erythropoietin should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when erythropoietin is administered to a nursing woman.

Precautions & Warnings

Erythropoietin should be used with caution in those patients with controlled hypertension, ischaemic vascular disease, history of seizures, or suspected allergy to the product.

Iron evaluation: Prior to and during Erythropoietin therapy, the patient's iron stores, including transferrin saturation and serum ferritin, should be evaluated. Transferrin saturation should be at least 20%, and ferritin should be at least 100 ng/ml. Virtually all patients will require supplemental Iron to increase or maintain transferrin saturation to levels that will adequately support erythropoiesis.

Overdose Effects

Doses of up to 1500 lU/kg TIW for 3 to 4 weeks have been administered to adults without any direct toxic effects. If the suggested target range is exceeded, drug therapy may be temporarily withheld until the hemoglobin returns to the suggested target range. If polycythemia is of concern, phlebotomy may be indicated to decrease the hemoglobin.

Storage Conditions

Erythropoietin should be stored at 2°C to 8°C. Protect from light. Do not freeze & avoid shaking.

Alternative brands of Erythropoietin

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.